David W.J. McGirr's Insider Trades & SAST Disclosures
David W.J. McGirr's most recent trade in Insmed Inc was a trade of 5,058 Common Stock done . Disclosure was reported to the exchange on May 15, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern David W.J. McGirr.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Insmed Inc | David W.J. McGirr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 5,058 | 103,973 (0%) | 0% | - | Common Stock | |
| Rhythm Pharmaceuticals Inc. | David W.J. McGirr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jun 2024 | 3,000 | 3,000 (0%) | 0% | - | Common Stock | |
| Rhythm Pharmaceuticals Inc. | David W.J. McGirr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jun 2024 | 3,000 | 0 | - | - | Restricted Stock Units | |
| Rhythm Pharmaceuticals Inc. | David W.J. McGirr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 14,000 | 14,000 | - | - | Stock Option (right to buy) | |
| Rhythm Pharmaceuticals Inc. | David W.J. McGirr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 4,000 | 4,000 | - | - | Restricted Stock Units | |
| X4 Pharmaceuticals Inc | David W.J. McGirr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 45,000 | 96,667 (0%) | 0% | 0 | Common Stock | |
| Insmed Inc | David W.J. McGirr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2024 | 13,162 | 98,915 (0%) | 0% | - | Common Stock | |
| Rhythm Pharmaceuticals Inc. | David W.J. McGirr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 14,000 | 14,000 | - | - | Stock Option (right to buy) | |
| Rhythm Pharmaceuticals Inc. | David W.J. McGirr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 3,000 | 3,000 | - | - | Restricted Stock Units | |
| Insmed Inc | David W.J. McGirr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 13,192 | 85,753 (0%) | 0% | - | Common Stock | |
| Rhythm Pharmaceuticals Inc. | David W.J. McGirr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| X4 Pharmaceuticals Inc | David W.J. McGirr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 6,667 | 6,667 (0%) | 0% | 0 | Common Stock | |
| Insmed Inc | David W.J. McGirr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2022 | 14,645 | 72,561 (0%) | 0% | - | Common Stock | |
| Rhythm Pharmaceuticals Inc. | David W.J. McGirr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| X4 Pharmaceuticals Inc | David W.J. McGirr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 6,000 | 6,000 | - | - | Stock Option (right to buy) | |
| Insmed Inc | David W.J. McGirr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 7,558 | 57,916 (0%) | 0% | - | Common Stock | |
| Rhythm Pharmaceuticals Inc. | David W.J. McGirr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2020 | 18,500 | 18,500 | - | - | Stock Option (right to buy) | |
| X4 Pharmaceuticals Inc | David W.J. McGirr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2020 | 3,427 | 3,427 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges